| 000 | 01827 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518061510.0 | ||
| 264 | 0 | _c20200113 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1475-6374 | ||
| 024 | 7 |
_a10.1080/14756366.2019.1664499 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuo, Wei-Yun | |
| 245 | 0 | 0 |
_aSynthesis and _h[electronic resource] |
| 260 |
_bJournal of enzyme inhibition and medicinal chemistry _cDec 2019 |
||
| 300 |
_a1678-1689 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xchemical synthesis |
| 650 | 0 | 4 |
_aArthritis _xdrug therapy |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aChromones _xchemical synthesis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFreund's Adjuvant |
| 650 | 0 | 4 |
_aInterleukin-6 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLipopolysaccharides _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRAW 264.7 Cells |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aChen, Liu-Zeng | |
| 700 | 1 | _aShen, Bang-Nian | |
| 700 | 1 | _aLiu, Xin-Hua | |
| 700 | 1 | _aTai, Guang-Ping | |
| 700 | 1 | _aLi, Qing-Shan | |
| 700 | 1 | _aGao, Li | |
| 700 | 1 | _aRuan, Ban-Feng | |
| 773 | 0 |
_tJournal of enzyme inhibition and medicinal chemistry _gvol. 34 _gno. 1 _gp. 1678-1689 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14756366.2019.1664499 _zAvailable from publisher's website |
| 999 |
_c30120834 _d30120834 |
||